Methods for optimizing nucleic acid libraries and mRNA
A nucleic acid library with diverse triplet codon sequences addresses mRNA stability and uptake issues, enhancing therapeutic efficacy through improved chemical stability and cellular integration.
Patent Information
- Application Number
- JP2024530425
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-24
- Filing Date
- 2022-11-24
- Publication Date
- 2024-11-26
AI Technical Summary
mRNA exhibits low stability and limited cellular uptake, necessitating improvements for therapeutic applications.
A library of nucleic acids with unique triplet codon sequences encoding the same polypeptide or its conservative substitutions is developed, allowing for efficient translation and identification of mRNAs with enhanced chemical stability.
The approach enables the creation of stable mRNA variants with improved shelf life and cellular uptake, facilitating effective therapeutic delivery.
Smart Images

Figure 2024543876000001 
Figure 2024543876000002
Abstract
Description
[Background technology]
[0001] There has been great interest in the development of messenger RNA (mRNA) as therapeutic agents and vaccines. However, mRNA has various drawbacks, such as low stability and very limited effective life in the human body. Also, mRNA is poorly taken up by cells. Therefore, methods for improving mRNA are needed. Summary of the Invention
[0002] The present invention provides libraries of nucleic acids, where each nucleic acid species of the library contains a unique sequence of triplet codons that encodes the same polypeptide, as well as methods of using such libraries for the identification of mRNAs that encode specific polypeptides having improved characteristics, e.g., with respect to improved chemical stability, while still allowing efficient translation in a target cell.
[0003] Disclosure of the Invention A "polypeptide" as used herein is a sequence of amino acids, i.e., a protein is also referred to herein as a polypeptide. The polypeptide is preferably of human origin. Also preferred are polypeptides derived from bacteria and viruses. Preferred polypeptides are those that can be used to induce a therapeutic effect. Also preferred are polypeptides that can be used to induce an immune response, such as polypeptides of viral or bacterial origin or polypeptides that can be used to induce an immune response against cancer cells. A particularly preferred polypeptide is the spike protein of SARS-CoV-2.
[0004] "Conservative amino acid substitution" as used herein refers to amino acid residues that are replaced with amino acid residues that have similar side chains.Families of amino acid residues that have similar side chains are defined in the art, including basic side chains (e.g., lysine, arginine or histidine), acidic side chains (e.g., aspartic acid or glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine or cysteine), non-polar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine or tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan or histidine).Therefore, if an amino acid in a polypeptide is replaced with another amino acid from the same side chain family, the amino acid substitution is considered to be conservative.
[0005] First Aspect—Library of Nucleic Acid Species In a first aspect, the present invention provides a library of nucleic acid species, at least 0.1% of the nucleic acid species comprise unique sequences of triplet codons that encode the same polypeptide or conservatively substituted versions of the polypeptide.
[0006] When referring to a nucleic acid species, what is meant is a nucleic acid species having a unique sequence in the library. 3 The library is 10 3 As used herein, two nucleic acid sequences that differ in sequence by at least one nucleotide are referred to herein as two nucleic acid species.
[0007] In other embodiments of the library, at least 0.000001%, 0.00001%, 0.0001%, 0.001%, 0.01%, 0.5%, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or 95% of the nucleic acid species comprise a unique sequence of triplet codons that encode the same polypeptide or conservatively substituted versions of the polypeptide.
[0008] Even more preferably, 99% of the nucleic acid species encode the same polypeptide or conservatively substituted versions of the polypeptide, such as 99.9%, 99.99% or 100%.
[0009] In most embodiments, it is preferred that all nucleic acid species encode the same polypeptide or conservatively substituted versions of the polypeptide, although it is recognized that errors in library generation may result in polypeptides that encode the same polypeptide less than 100% of the time.
[0010] For all embodiments of the invention, it is preferred that the nucleic acid species encode the same polypeptide or conservatively substituted versions of the polypeptide, and it is even more preferred that the nucleic acid species encode the same polypeptide.
[0011] In preferred embodiments, the nucleic acid species is comprised of RNA, such as mRNA, or is comprised of DNA, for example single-stranded or double-stranded DNA.
[0012] Due to the degenerate genetic code, many different nucleic acid species can encode the same polypeptide, and multiple synonymous triplet codons can encode the same amino acid. Thus, in a preferred embodiment, the nucleic acid species of the library differ in their usage of (synonymous) codons for particular amino acids.
[0013] The term "encode" as used herein with respect to triplet codons applies to both triplet codons in RNA and triplet codons in DNA that can be converted to the corresponding triplet codons in RNA using RNA transcription. Thus, triplet codons in DNA contain T (thymidine) instead of U (uridine).
[0014] Listed here are the synonymous codons for the various amino acids as well as the start and stop codons. Ala / A: GCU, GCC, GCA, GCG Arg / R:CGU, CGC, CGA, CGG, AGA, AGG Asn / N:AAU, AAC Asp / D:GAU,GAC Cys / C: UGU, UGC Gln / Q: CAA, CAG Glu / E:GAA, GAG Gly / G: GGU, GGC, GGA, GGG His / H: CAU, CAC Ile / I:AUU, AUC, AUA Leu / L:UUA, UUG, CUU, CUC, CUA, CUG Lys / K:AAA, AAG Met / M:AUG Phe / F: UUU, UUC Pro / P: CCU, CCC, CCA, CCG Ser / S:UCU, UCC, UCA, UCG, AGU, AGC Thr / T: ACU, ACC, ACA, ACG Trp / W:UGG Tyr / Y: UAU, UAC Val / V:GUU,GUC,GUA,GUG Start:AUG Stop: UAG, UGA, UAA
[0015] Preferred synonymous codons are those known to provide robust translation of mRNA in the target cell or those that have high levels of tRNA in the target cell. In one embodiment, poorly translated codons are not used.
[0016] By using synonymous codons at various positions in a nucleic acid such as an mRNA (or part of an mRNA), a nucleic acid library of very large size can be created. This is similar to RNA or DNA libraries created for SELEX, or libraries for mRNA display or phage display, where experience has shown that large libraries allow the identification of new molecular functions and activities. However, in these cases, the library members do not contain unique sequences of triplet codons that code for the same polypeptide. When such libraries (mRNA display and phage display libraries) contain open reading frames in the form of sequences of triplet codons, the goal is most often not to preserve the amino acid (aa) sequence of the encoded polypeptide. On the contrary, the goal is to change the sequence of the triplet codons so that the aa sequence of the encoded polypeptide is also changed. This is necessary in order to be able to identify new polypeptide sequences with desired characteristics, for example improved binding to a receptor or thermal stability.
[0017] In the present invention, large libraries are used to search the vast structural space of nucleic acid species that have the sequence of triplet codons that code for the same polypeptide or conservatively substituted versions of the polypeptide.Given the size of the library that can be made as outlined herein, and the fragile regions in mRNA reading frames are influenced by primary (sequence), secondary and tertiary structures, large libraries of mRNAs that have triplet codons that code for the same polypeptide (or conservatively substituted versions of the polypeptide) allow the identification of mRNAs with improved characteristics such as chemical stability, thus improving the shelf life of mRNAs.
[0018] Library size and number of copies In one embodiment, the library comprises at least 10 3 different nucleic acid species, e.g., at least 10 4 , 10 5 , 10 7 , 10 8 , 10 9 , 10 10 , 10 11 , 10 12 , 10 13 , 10 14 The nucleic acid sequence includes nucleic acid species.
[0019] In another preferred embodiment, the library comprises at least 10 nucleotide sequences that all differ in their open reading frames, i.e., in codon usage. 3 different nucleic acid species, e.g., at least 10 1 , 10 2 , 10 3 , 10 4 , 10 5 , 10 7 , 10 8 , 10 9 , 10 10 , 10 11 , 10 12 , 10 13 or 10 14 and preferably all encode the same polypeptide.
[0020] In yet another preferred embodiment, the library comprises at least 5, at least 10, at least 50, at least 10 2 , at least 10 3 , at least 10 4 , at least 10 5 , at least 10 6 , at least 10 7 , at least 10 8 , at least 10 9 , at least 10 10 , at least 10 11 , at least 10 12 , at least 10 13 , at least 1014 , 10~10 14 , 10 2 ~10 14 , 10 3 ~10 13 , 10 4 ~10 11 , 10 5 ~10 10 , 10 6 ~10 9 , 10 3 ~10 14 , 10 4 ~10 14 , 10 5 ~10 14 , 10 6 ~10 14 , 10 7 ~10 14 , 10 3 ~10 12 , 10 4 ~10 12 , 10 5 ~10 12 , 10 6 ~10 12 and 10 7 ~10 12 The nucleic acid sequence includes a number of nucleic acid species each of which comprises a unique sequence of triplet codons selected from the group consisting of:
[0021] The copy number of each nucleic acid species can be adjusted as needed. In a preferred embodiment, the copy number of each nucleic acid species in the library is between 1 and 10 9 , e.g. 10~10 8 , 10 2 ~10 7 , 10 3 ~10 6 and 10 4 ~10 5 In another embodiment, the copy number of each nucleic acid species in the library is at least 10 1 , 10 2 , 10 3 , 10 4 , 10 5 , 10 7 , 10 8 , 10 9 , 10 10 , 10 11 , 1012 , 10 13 or 10 14 It is.
[0022] In one embodiment, the copy number of each nucleic acid species in the library varies by less than 10-fold, or by less than 9-fold, 8-fold, 7-fold, 6-fold, 5-fold, 4-fold, 3-fold, or 2-fold. The preferred copy number depends on the library size, such that for practical reasons the copy number may be greater in small libraries than in large libraries.
[0023] Length of nucleic acid species Preferably, the sequence of the triplet codon is at least 3 nucleotides, at least 6 nucleotides, at least 9 nucleotides, at least 12 nucleotides, at least 15 nucleotides, at least 18 nucleotides, at least 21 nucleotides, 24 nucleotides, at least 27 nucleotides, at least 30 nucleotides, at least 33 nucleotides, at least 36 nucleotides, at least 39 nucleotides, at least 42 nucleotides, at least 45 nucleotides, at least 48 nucleotides, at least 51 nucleotides, 54 nucleotides, at least 57 nucleotides, at least 60 nucleotides, at least 75 nucleotides, at least 90 nucleotides, at least 105 nucleotides, at least 120 nucleotides, at least 150 nucleotides. The leotide has a length selected from the group consisting of at least 180 nucleotides, at least 210 nucleotides, at least 240 nucleotides, at least 270 nucleotides, at least 300 nucleotides, at least 600 nucleotides, at least 900 nucleotides, at least 1200 nucleotides, at least 1500 nucleotides, at least 1800 nucleotides, at least 2100 nucleotides, at least 2400 nucleotides, at least 2700 nucleotides, at least 3000 nucleotides, 6-6000 nucleotides, 60-6000 nucleotides, 600-6000 nucleotides, 600-6000 nucleotides, 6-4500 nucleotides, 60-4500 nucleotides, 300-4500 nucleotides and 600-4500 nucleotides.
[0024] When the nucleic acid is RNA, the sequence of the triplet codon is at least 30 nucleotides, at least 60 nucleotides, at least 90 nucleotides, at least 105 nucleotides, at least 120 nucleotides, at least 150 nucleotides, at least 180 nucleotides, at least 210 nucleotides, at least 240 nucleotides, at least 270 nucleotides, at least 300 nucleotides, at least 600 nucleotides, at least 900 nucleotides, at least 1200 nucleotides, at least 1500 nucleotides, at least 1800 nucleotides, at least 2100 nucleotides, at least 2400 nucleotides, at least 2700 nucleotides, at least 3000 nucleotides, 60 to 6000 nucleotides, 6 to 6000 nucleotides, 6 to 4500 nucleotides, 60 to 4500 nucleotides, 300 to 4500 nucleotides and 600 to 4500 nucleotides.
[0025] The length of the polypeptide (encoded by the nucleic acid) can be from 10 amino acids (aa) to 10,000 aa. More preferably, the polypeptide can have a length of at least 20 aa, such as at least 30, 40, 50, 60, 70, 80, 90, 100, 200, 300, 400, 500, 600, 700, 800, 900, 1100, 1200, 1300, 1400 and 1500 aa.
[0026] Importantly, the nucleic acid species of the library does not necessarily code for a polypeptide corresponding to a full-length naturally occurring protein.Nucleic acid species such as mRNA species may be sufficient to code for only a part of a naturally occurring protein, preferably a human, bacterial or viral protein.In addition, the mRNA species of the library may be less suitable for translation, since it lacks certain elements that can be added later if or when translation is required.The key is that the mRNA has a sequence of codons (open reading frame or ORF) that corresponds to and codes for a polypeptide.
[0027] In a preferred embodiment, a sequence of triplet codons encoding the same polypeptide naturally encodes a full-length naturally occurring polypeptide.
[0028] Fixed and variable regions The triplet codon (and corresponding open reading frame) sequences of the nucleic acid species in the library can be divided into invariant and variable regions. When referring to invariant and variable regions with respect to the nucleic acid species in a nucleic acid library, the invariant regions are those that are shared among all nucleic acid species in the library, and the variable regions are those that are not shared among all nucleic acid species in the library.
[0029] Invariant regions may also be referred to as fixed regions or regions that are conserved among all nucleic acid species in a library. Similarly, variable regions may also be referred to as non-conserved regions that are not conserved among all nucleic acid species in a library.
[0030] In many cases, the sequence of a triplet codon contains both a variable region and an invariant region. In these cases, two different synonymous triplet codons are seen as a variable region of three nucleotides, even though only one nucleotide may differ between the two synonymous codons. The fact that the sequence of a triplet codon often contains both a variable region and an invariant region is a consequence of the enormous diversity possible through the use of synonymous codons. Even if only the two best synonymous codons for each amino acid (e.g., corresponding to the most highly expressed tRNAs) were used, the sequence of the 50 triplet codons would be 2 50 =1.13×10 15 Therefore, the total length of the variable region in the triplet codon sequence is preferably 150 nucleotides or less. It is even more preferred that the total length of the variable region in the triplet codon sequence is 120 nucleotides or less, for example 105 nucleotides, 90 nucleotides, 75 nucleotides, 60 nucleotides, 45 nucleotides, 30 nucleotides, 15 nucleotides, 12 nucleotides, 9 nucleotides and 6 nucleotides.
[0031] In most cases, the nucleotides outside the triplet codon sequence are not variable, but there are cases where it may be interesting to create variable regions outside the triplet codon sequence, for example to stabilize the 5'UTR or 3'UTR of the mRNA or the combination of the 5'UTR or 3'UTR with the triplet codon sequence.
[0032] Preferably, the nucleic acid species of the library share a first fixed sequence downstream of the sequence of the triplet codon.
[0033] In one embodiment, the first fixed sequence comprises at least a portion of a sequence corresponding to the 3' UTR (3' untranslated region) of a naturally occurring mRNA. The first fixed sequence preferably has a length of 10 to 1000 nucleotides.
[0034] As used herein, the term "corresponding to" means that a sequence is identical to a DNA version of an RNA sequence, or an RNA version of a DNA sequence.
[0035] In another embodiment, it is preferred that the nucleic acid species share a second fixed sequence upstream of the sequence of the triplet codon.
[0036] The second fixed sequence may comprise at least a portion of a sequence corresponding to the 5' UTR (5' untranslated region) of a naturally occurring mRNA. Preferably, the length of the second fixed sequence is 10 to 1000 nucleotides. In a preferred embodiment, the second fixed sequence comprises sequences corresponding to elements that promote translation, such as a Kozak sequence, an IRES element (internal ribosome entry site), a 5' CAP and an initiation codon.
[0037] In a preferred embodiment, the second fixed sequence comprises a promoter sequence or a sequence corresponding to a promoter sequence for RNA transcription. Preferred promoter sequences are those that allow transcription by T7 RNA polymerase, SP6 RNA polymerase and Syn5 RNA polymerase.
[0038] In a preferred embodiment, the nucleic acid species of the library share both a first fixed sequence downstream of the sequence of the triplet codon and a second fixed sequence upstream of the sequence of the triplet codon.
[0039] When the library of the invention is composed of DNA, the second fixed sequence preferably comprises a promoter allowing the transcription of a DNA sequence of a triplet codon into a corresponding RNA sequence of the triplet codon.
[0040] When the library of the invention is composed of RNA, the second fixed sequence typically does not contain a promoter that allows RNA transcription. However, a promoter sequence can be added by reverse transcription of the RNA into cDNA using a primer bound to the first fixed sequence, and by second strand synthesis initiated with a primer that uses the cDNA as a template and contains at its 5' end a promoter sequence for RNA transcription and at its 3' end a sequence corresponding to the second fixed region.
[0041] A preferred form of RNA is mRNA. In such embodiments, the invention provides a library of mRNA species, wherein at least 50% of the mRNA species of the library encode the same polypeptide or conservatively substituted versions of the polypeptide. Even more preferably, at least 60%, 70%, 80%, 90% or 95% of the mRNA species encode the same polypeptide or conservatively substituted versions of the polypeptide. Even more preferably, 99% of the mRNA species encode the same polypeptide or conservatively substituted versions of the polypeptide, such as 99.9%, 99.99% or 100%.
[0042] In a more preferred embodiment, the invention provides a library of mRNA species, wherein at least 50% of the mRNA species in the library encode the same polypeptide. Even more preferably, at least 60%, 70%, 80%, 90% or 95% of the mRNA species encode the same polypeptide. Even more preferably, at least 99% of the mRNA species encode the same polypeptide, such as 99.9%, 99.99% or 100%.
[0043] An mRNA species may include a 5'UTR and / or a 3'UTR. Also, the 5'UTR and 3'UTR regions may be conserved among the mRNA species of the library. Alternatively, the 5'UTR and 3'UTR may vary among the mRNA species of the library.
[0044] In some embodiments, the mRNA species includes elements necessary to facilitate translation, such as a Kozak sequence, an IRES element, a 5' CAP and a start codon, while in other embodiments, such elements are absent.
[0045] In one embodiment, the mRNA species are circularized prior to selection for a desired characteristic, such as chemical stability.
[0046] Importantly, the ribonucleotides of the mRNA species of the library are not necessarily limited to the four standard ribonucleotides of RNA: adenine (A), guanine (G), cytosine (C) or uracil (U). In a preferred embodiment, pseudouridine or 1-methyl-3'-pseudouridylyl is included in the RNA or mRNA species, preferably in place of uridine. Other non-standard ribonucleotides may also be included, such as 5-methylcytosine in place of cytosine. Phosphorothioate linkages may also be included.
[0047] Short nucleic acid library In particular embodiments, the nucleic acid species of the libraries of the invention are short and can be prepared using standard oligonucleotide synthesis. These libraries of short nucleic acid species can be used to assemble libraries of longer nucleic acid species that have multiple variable regions in the sequence of triplet codons.
[0048] In this particular embodiment, the first and second fixed sequences each preferably have a length of 10 to 50 nucleotides, more preferably 12 to 40, 13 to 30 or 14 to 25 nucleotides. In this embodiment, it is also preferred that the nucleic acid species is single-stranded DNA or double-stranded DNA. Furthermore, it is preferred that the triplet codon sequence has a length selected from the group consisting of 3 to 300 nucleotides, 3 to 150 nucleotides, 3 to 120 nucleotides, 3 to 90 nucleotides, 3 to 60 nucleotides, 3 to 45 nucleotides, 3 to 30 nucleotides, 3 to 15 nucleotides, 6 to 300 nucleotides, 6 to 150 nucleotides, 6 to 120 nucleotides, 6 to 90 nucleotides, 6 to 60 nucleotides, 6 to 45 nucleotides, 6 to 30 nucleotides and 6 to 15 nucleotides. And preferably, the number of nucleic acid species (each of which) comprises a (unique) sequence of triplet codons is selected from the group consisting of at least 5, at least 10, at least 50, at least 100, at least 1000, between 3 and 1000, between 6 and 1000, between 6 and 500, between 6 and 300, between 6 and 100, between 6 and 50. As the number of nucleic acid species is relatively small in this particular embodiment, the nucleic acid species may be synthesised individually and subsequently mixed in equimolar amounts to generate the library.
[0049] When the library of short nucleic acids of the present invention is used to assemble a larger library of longer nucleic acids, multiple libraries of short nucleic acids are required, and the nucleic acid species of each library of short nucleic acids have a sequence of triplet codons that encode the same polypeptide, but the encoded polypeptide is not the same for the different libraries of short nucleic acids. However, the polypeptides of the different libraries of short nucleic acids are preferably part of the same naturally occurring polypeptide.
[0050] Preparation of the library of the present invention The library of nucleic acid species, either RNA or DNA, can be prepared using standard methods for RNA and DNA synthesis, for example based on phosphoramidate building blocks.Nucleic acid species can be synthesized separately, and species can be pooled afterwards.Chemical synthesis is particularly suitable for libraries of nucleic acid species with shorter lengths, such as less than 500 nucleotides, less than 400 nucleotides, less than 300 nucleotides, less than 200 nucleotides, less than 150 nucleotides or less than 100 nucleotides.
[0051] For mRNA libraries with longer mRNA species, enzymatic synthesis, such as in vitro RNA transcription, is the preferred method for making libraries.Thus, the mRNA species of the library of the present invention can be synthesized, for example, using SP6 RNA polymerase, T7 RNA polymerase or Syn5 RNA polymerase.
[0052] Obviously, RNA transcription requires a DNA template, and the DNA template for transcription must contain sequences that correspond to (can direct the synthesis of and encode) the mRNA species in the mRNA library, i.e., the DNA template must be a DNA template library that contains DNA species that correspond to the mRNA species in the mRNA library. In addition to the sequences in the mRNA library, the DNA library must contain a promoter for RNA transcription, preferably a promoter for SP6 RNA polymerase or T7 RNA polymerase or Syn5 RNA polymerase.
[0053] If a larger size library is required, it is desirable to use a split pool protocol. In such a protocol, standard RNA or DNA synthesis is performed until the variable region is synthesized. If the codon to be changed first codes for leucine, for example, the oligonucleotide synthesis reaction can be divided into four side reactions. In each of these side reactions, one codon that codes for leucine is added (one synonymous codon per side reaction, four synonymous codons in total for the four side reactions). The four side reactions can then be pooled (mixed) and then the pooled reaction can be split before adding the next changed codon position. Of course, the conserved codon is added without splitting the reaction. The principles of split pool synthesis are well known. An advanced form of split pool synthesis is used for the creation of DNA-encoded chemical libraries, where the DNA-tags code for chemical compounds, i.e. the molecules are bifunctional and bidirectional. In a preferred embodiment, the DNA-encoded chemical libraries prepared by split pool synthesis are not part of the present invention.
[0054] An alternative to using split mix synthesis is to generate trimer phosphoramidites corresponding to all aa codons. If a particular codon position, for example leucine, is to be changed during synthesis, four synonymous trimer phosphoramidite codons encoding leucine are added to the reaction in a ratio that results in the desired ratio of codons. Here, of course, the reaction factors for the various trimer phosphoramidite codons must be taken into account. Trimer codons for all aa are commercially available, and those skilled in the art can synthesize synonymous trimer phosphoramidite codons that are not commercially available.
[0055] In the case of synthesis of longer DNA templates that may be difficult to synthesize chemically, the DNA synthesis may be divided into shorter subsequences that are then assembled into the desired full-length sequence, for example using PCR tricks. The above library of short nucleic acids is a preferred embodiment of such subsequences. As mentioned above, when the library of short nucleic acids of the present invention is used to assemble a larger library of longer nucleic acids, multiple libraries of short nucleic acids are required, and the nucleic acid species of each library of short nucleic acids have a sequence of triplet codons that code for the same polypeptide, but the encoded polypeptide is not the same for different libraries of short nucleic acids. However, the polypeptides of different libraries of short nucleic acids are preferably part of the same naturally occurring polypeptide.
[0056] The subsequences may be assembled using enzymatic or chemical ligation. A preferred method of assembling the subsequences is by having the subsequences act as primers and templates for each other in assembly PCR. In this embodiment, the subsequences contain overlapping sequences so that the subsequences can anneal to each other to facilitate assembly. Also, it is preferred that the overlapping sequences are within conserved regions of the mRNA library. It is not necessary for all subsequences used to assemble a longer library of nucleic acid species to contain variable regions. That is, the subsequences can have sequences that correspond to the parent mRNA.
[0057] Selection of variable regions for library species As mentioned above, there is a limit to the length of the variable region in the triplet codon sequence, since there is an upper limit to the diversity based on the number of molecules. Therefore, for an mRNA with a certain number of codons, it is not possible to change all codon positions with all synonymous codons.
[0058] Even if only the two best synonymous codons for each amino acid (e.g., corresponding to the most highly expressed tRNAs) were used, the sequence of 50 triplet codons would be 250 =1.13×10 15 Therefore, for longer sequences of triplet codons, it is necessary to choose regions that use synonymous codons to create variable regions.
[0059] In a preferred embodiment, the variable regions within the sequence of the triplet codon are selected based on fragile regions and sites in the mRNA. Thus, if the goal is to improve the stability of a particular mRNA, for example, the mRNA encoding the spike protein of SARS-CoV-2, the mRNA of interest is first synthesized, for example, using T7 RNA polymerase. The mRNA is then incubated under conditions where it is desired to improve the stability of the mRNA. The degradation of the mRNA is then tracked over time, and the degradation fragments are used to identify fragile regions and sites in the mRNA. The degradation fragments are visualized by gel electrophoresis, isolated from the gel, and the sequences of the degradation fragments are obtained using RNA-seq.
[0060] Once the most fragile regions and sites of an mRNA are identified, a library of nucleic acid species is created in which the codons around the fragile regions and / or sites are modified using synonymous codons. In this way, the primary, secondary and tertiary structures around the fragile regions and sites are altered without changing the amino acid sequence of the polypeptide encoded by the mRNA. Altering the structure around the fragile regions and sites can be used to prevent the mRNA from breaking down at a given region and / or site, thereby stabilizing the mRNA. For example, a seven-codon variable region, each with two synonymous codons, can be introduced into the fragile site, for example, the fragile site is centrally located in the variable region. This gives a variable region of 256 sequences, some of which have reduced fragility. A variable region of eight codons, each with two synonymous codons, gives a variable region of 1024 sequences, improving the probability of finding a sequence with reduced fragility. In one embodiment, codons of the parent version of the mRNA to be stabilized are omitted in the variable region to create a structure as different as possible from the parent version. Of course, the fragile region and the variable region surrounding the site can be longer and can use more than two synonymous codons or all synonymous codons for a given amino acid. For example, 40 codon positions surrounding the fragile site can be changed with two synonymous codons, resulting in 2 synonymous codons. 40 =1.1×10 12 This provides a diversity and library size of 10 ...
[0061] Fragile regions and sites in an mRNA can be stabilized one at a time, especially if they are separated by a certain distance in the original mRNA sequence, for example at least 50 nucleotides or at least 100 nucleotides.
[0062] In another embodiment, the original mRNA is split into shorter fragments of 100-500 nucleotides that are individually stabilized.
[0063] In a preferred embodiment, the library of stabilized shorter mRNA fragments (or DNA sequences corresponding to mRNA fragments) can be shuffled to generate a library of nucleic acids that code for full-length polypeptides, and this library can be used to select the most stable full-length mRNA.After selecting the most stable full-length mRNA, the process can be started again by identifying the most vulnerable sites and regions of the already stabilized mRNA.
[0064] Second Aspect—Method of Selecting mRNA Species A second aspect of the present invention provides a method for selecting an mRNA species having a particular characteristic in an mRNA library according to the first aspect of the present invention, comprising the steps of: a. providing a library of mRNA species according to the first aspect of the invention; b. selecting mRNA species having certain characteristics; Includes.
[0065] Certain characteristics – stability In a preferred embodiment, a particular characteristic is RNA stability, such as chemical or biological stability. Thus, the mRNA library is incubated under conditions that result in at least some degradation of the mRNA.
[0066] This can be, for example, HO, saline, or a solution expected to stabilize the RNA, such as a pharmaceutical formulation optimized for a long shelf life. 2+ Other divalent cations may also be included, such as , which often catalyze the hydrolysis of RNA.
[0067] Temperature is also a suitable parameter to adjust and can be any temperature at which it is desired to identify mRNA species with improved stability. Thus, the temperature can be 4°C, 20°C, 37°C, or higher. It may also be desired to identify mRNA species with improved stability in the frozen state, for example at -20°C or -80°C. A combination of conditions may also be used.
[0068] For example, one may expose an mRNA library to serum, plasma or blood to select for mRNA species with the greatest stability under those conditions.
[0069] To select the mRNA species with the best stability in cells, the mRNA library can be transfected into cells. Alternatively, to select the most stable mRNA species, the mRNA library can be exposed to cell lysates.
[0070] Preferably, the mRNA library should be incubated under given conditions for a certain time that results in enrichment of more stable mRNA species over less stable mRNA species.Preferably, the incubation time results in at least 50% of all mRNA in the library, for example at least 60%, 70%, 80%, 90%, 95%, 99%, 99.9%, 99.99%, 99.999%, 99.9999u% being no longer completely intact, or all mRNA in the library being no longer completely intact.In a preferred embodiment, at least 0,001% of mRNA, for example at least 0,01% or 0,1% are still intact.
[0071] Certain characteristics - activity A particular characteristic may also be the ability to be internalized into a cell. In this embodiment, the mRNA library may be incubated with one or more cells, and then RNA is purified from the cells to select for internalized mRNA species.
[0072] A particular feature may also be translation efficiency. In such an embodiment, an mRNA species may be used for mRNA display, in which the encoded polypeptide is covalently linked to the mRNA species if the mRNA species is translated to completion. Thus, if a given mRNA species is translated poorly or slowly, such an mRNA species may be excluded from the library by selecting only those mRNAs that produce full-length polypeptides under given conditions. Selecting such an mRNA may be performed using an antibody against the encoded polypeptide, since if the mRNA species is translated efficiently, the encoded polypeptide is covalently linked to the mRNA species. Another option is to add a tag, such as a GST tag or a His tag, to the c-terminus of the polypeptide, which can be used to select full-length proteins.
[0073] In another preferred embodiment, a particular characteristic is the immunostimulatory activity of the mRNA species of the library, with lower immunostimulatory activity being more desirable.
[0074] Identification After selection, the selected mRNA species can be identified by sequencing, for example by RT-PCR followed by cloning and sequencing, or the mRNA species can be sequenced using RNA-seq.
[0075] Iterative Rounds The selected mRNA species can also be subjected to RT-PCR to generate a new DNA library with a promoter for RNA transcription. This DNA library can then be used to generate a second generation mRNA library enriched with the mRNA species selected in the previous round. Here, this second generation mRNA library can be further enriched by performing another step of selecting mRNA species with a certain characteristic, which can be the same as in the first round of selection. The certain characteristic can also be different from the selection criteria used in the first round, such as stability in a different buffer or at a different temperature. The selection criteria can be stability in the same buffer, but a more stringent selection achieved by a longer incubation time. The selection criteria in the first round can be stability under certain conditions, and the selection criteria in the second round can be translation efficiency.
Claims
1. A library of nucleic acid species, at least 99% of the nucleic acid species comprising a unique sequence of triplet codons encoding the same polypeptide, the library comprising at least 10 2 A library of nucleic acid species, comprising:
2. A library of nucleic acid species, at least 99% of the nucleic acid species comprising a unique sequence of triplet codons encoding the same polypeptide, the library comprising at least 10 6 A library of nucleic acid species, comprising:
3. The library according to claim 1 or 2, wherein the sequence of triplet codons has a length of 60 to 6000 nucleotides.
4. 4. The library of any one of claims 1 to 3, wherein the nucleic acid species of the library share both a first fixed sequence downstream of the sequence of a triplet codon and a second fixed sequence upstream of the sequence of a triplet codon.
5. The library of any one of claims 1 to 4, wherein the second fixed sequence comprises at least a portion of a sequence corresponding to the 5'UTR (5' untranslated region) of a naturally occurring mRNA.
6. The library of any one of claims 1 to 5, wherein the first fixed sequence comprises at least a portion of a sequence corresponding to the 3'UTR (3' untranslated region) of a naturally occurring mRNA.
7. The library according to any one of claims 1 to 6, wherein the second fixed sequence comprises at least a portion of a sequence corresponding to an element that enhances translation, such as a Kozak sequence, an IRES element, a 5'CAP and an initiation codon.
8. The library of any one of claims 1 to 7, wherein the first fixed sequence and the second fixed sequence each have a length of 10 to 30 nucleotides for PCR amplification.
9. 10. The library of claim 9, wherein the sequences of triplet codons encoding the same polypeptide have a length selected from the group consisting of: 3-300 nucleotides, 3-150 nucleotides, 3-120 nucleotides, 3-90 nucleotides, 3-60 nucleotides, 3-45 nucleotides, 3-30 nucleotides, 3-15 nucleotides, 6-300 nucleotides, 6-150 nucleotides, 6-120 nucleotides, 6-90 nucleotides, 6-60 nucleotides, 6-45 nucleotides, 6-30 nucleotides and 6-15 nucleotides.
10. The library of any one of claims 1 to 9, wherein the nucleic acid species are composed of DNA or RNA.
11. The library of any one of claims 1 to 10, wherein the second fixed sequence comprises a promoter sequence or a sequence corresponding to a promoter sequence for RNA transcription.
12. 1. A method for identifying mRNA species having a particular characteristic in an mRNA library, comprising: a. Providing a library of mRNA species according to any one of claims 1 to 11; b. Selecting mRNAs that identify a particular characteristic; A method comprising:
13. The method of claim 12, wherein the selected mRNA species is identified by sequencing.
14. a. reverse transcription and PCR amplification of selected mRNA species to generate DNA templates for RNA transcription; b. RNA transcription using the DNA template generated in the previous step to generate a second generation mRNA library enriched for mRNA species having the specified characteristics; 14. The method of claim 12 or 13, further comprising:
15. The method according to any one of claims 12 to 14, wherein the certain characteristic is selected from the group consisting of biostability, chemical stability and translational efficiency.
